US FDA Gives More Time For Public Response To NGS Microbial Identification Guidance
Executive Summary
To give stakeholders more time to respond, FDA has extended its comment period on a draft guidance that addresses next-generation sequencing tests that are used to detect microbes and antimicrobial resistance.